Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Dr. Qianheng Jin | Medicine and Health Sciences | Attending physician | Suzhou Ruihua Orthopedic Hospital | China

Dr. Qianheng Jin is a highly accomplished physician and researcher whose work bridges clinical orthopedics and regenerative medicine. With a career rooted in advancing patient care, he has combined surgical expertise with pioneering biomedical research, focusing on innovative approaches in tissue engineering, wound healing, and bioprinting. His professional journey highlights a consistent commitment to improving treatment outcomes, particularly in complex reconstructive procedures and vascularized tissue regeneration. Dr. Qianheng Jin is recognized for integrating advanced research into clinical practice, making significant contributions to both academic science and applied medical solutions that directly benefit patients.

Professional Profile 

Education

Dr. Qianheng Jin pursued his advanced medical and doctoral studies at Soochow University, where he specialized in the fields of orthopedic surgery, regenerative medicine, and biomedical engineering. His academic training emphasized translational research, with a focus on developing engineered tissues and vascularized constructs capable of improving clinical outcomes in reconstructive surgery. Through rigorous education and extensive research engagement, Dr. Qianheng Jin has cultivated deep expertise in surgical techniques, tissue biology, and biomaterial applications, which now form the foundation of his academic and clinical contributions.

Experience

Dr. Qianheng Jin serves as a physician at Suzhou Ruihua Orthopedic Hospital, where he applies his knowledge in treating complex injuries and performing advanced replantation surgeries. His professional experience is characterized by a balance between hands-on surgical practice and groundbreaking laboratory-based innovations. In his role, he has contributed to the establishment of emergency protocols for major limb replantation, leading to significant improvements in patient outcomes. Beyond clinical service, he has actively participated in collaborative research projects that link medical institutions and international academic communities. This blend of professional experience underscores his ability to merge theory and practice while fostering a collaborative research culture.

Research Interest

The research interests of Dr. Qianheng Jin lie in the intersection of regenerative medicine, bioprinting technologies, and clinical orthopedics. His work particularly focuses on the development of engineered dermal tissues, small-diameter vascular grafts, and advanced wound healing strategies. He has contributed to the exploration of bioprinted vascularized constructs that mimic natural tissue structures and improve graft survival. Additionally, his studies extend to investigating molecular mechanisms that influence tissue repair and regeneration, offering valuable insights into translational applications. Dr. Qianheng Jin work demonstrates his dedication to advancing clinical solutions through innovative biomedical technologies that address unmet challenges in reconstructive medicine.

Award

Dr. Qianheng Jin has been recognized for his contributions through academic excellence, impactful research, and clinical innovation. His published works in highly respected journals highlight his role as a thought leader in regenerative medicine and bioprinting. These achievements underscore his eligibility for awards that honor research excellence, clinical impact, and international collaboration. His record reflects not only scholarly productivity but also the translation of research into practical applications, affirming his status as a deserving candidate for this nomination.

Selected Publication

  • A multidisciplinary emergency protocol reduces revascularization time in major upper and lower limb replantations (2025) – 18 Citations

  • Bioprinted dermis with human adipose tissue‐derived microvascular fragments promotes wound healing (2024) – 32 Citations

  • Engineered dermis loaded with confining forces promotes full-thickness wound healing by enhancing vascularisation and epithelialisation (2023) – 27 Citations

  • Bioprinting small diameter blood vessel constructs with an endothelial and smooth muscle cell bilayer in a single step (2020) – 41 Citations

Conclusion

Dr. Qianheng Jin exemplifies the qualities of an outstanding clinician-researcher whose dedication to advancing science and medicine has resulted in significant contributions to orthopedic surgery, regenerative medicine, and biomedical engineering. His career reflects a rare balance between direct patient care and innovative research, producing outcomes that resonate within both clinical practice and global academic discourse. With a growing body of high-impact publications, international collaborations, and leadership in clinical innovation, Dr. Qianheng Jin continues to pave the way for advancements in reconstructive medicine. His achievements, professional dedication, and potential for future breakthroughs make him an exceptional candidate for this award nomination, representing both scientific excellence and meaningful societal contribution.

 

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Anne Vertigan, John Hunter Hospital, Australia

Assoc. Prof. Dr. Anne Vertigan is an experienced Speech Pathologist with a career spanning over 30 years. She holds multiple degrees, including a PhD in chronic cough and airway hyperresponsiveness. Dr. Vertigan is the Director of Speech Pathology at Greater Newcastle Acute Hospital and has extensive experience in leadership and clinical roles. She has contributed significantly to research, focusing on chronic cough, laryngeal dysfunction, and asthma. Dr. Vertigan has been invited to speak at numerous international conferences and has received several prestigious grants. She is also an Associate Editor for the European Respiratory Journal. 📚🎤💬👩‍⚕️🌏

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Anne Vertigan holds a B.App.Sc. (Speech Pathology) from La Trobe University (1991), an MBA from the University of Newcastle (2008), and a PhD from the University of Queensland, where she researched chronic cough and extrathoracic airway hyperresponsiveness syndrome, awarded in 2007. She also earned a Master in Clinical Epidemiology (2023) and a Master in Medical Statistics (2023) from the University of Newcastle. Dr. Vertigan’s academic and professional journey reflects her commitment to advancing knowledge in health, particularly in respiratory conditions and clinical research. 📚🎓💡🩺

Experience

Assoc. Prof. Dr. Anne Vertigan is a seasoned speech pathologist with an extensive career in healthcare leadership. She has served as the Director of Speech Pathology at the Greater Newcastle Acute Hospital Network since 2000. Previously, Dr. Vertigan was a Post-Doctoral Research Fellow at the NHMRC Centre for Clinical Excellence in Respiratory & Sleep Medicine (2008-2009). Her roles include District Profession Director of Speech Pathology at Hunter New England Health (2008-2015) and Director at John Hunter Hospital (1994-2000). With additional experience in various hospitals and community health centers, Dr. Vertigan has made significant contributions to speech pathology and healthcare. 🏥👩‍⚕️📚

Presentations

Assoc. Prof. Dr. Anne Vertigan is a renowned expert in laryngeal dysfunction, chronic cough, and voice disorders, delivering numerous invited talks at prestigious international conferences. In June 2024, she spoke at the Inducible Laryngeal Obstruction Conference in Pittsburgh, USA, on topics such as the hypersensitive larynx, laryngeal dysfunction, and the relationship between inducible laryngeal obstruction (ILO) and severe asthma. She also addressed dysphagia management and laryngeal hyperresponsiveness at the Phonosurgery Association of India in February 2024. Additionally, Dr. Vertigan shared her expertise at the French Society of ENT Congress and the ENT Head & Neck Instructional Course in Singapore. 🌍🎤👩‍⚕️

Grants

Assoc. Prof. Dr. Anne Vertigan has been awarded several prestigious grants and recognitions for her research in respiratory health. These include the $10,000 Ignite EMCR Equipment Grant (2018) for BioRadio Respiratory Inductive Plethysmography, and the $5,000 Strategic Research Pilot Grant (2020) to understand breathlessness in asthma. She also contributed to the $320,490.62 Medical Research Futures Fund on bushfire impact (2020), and the NHMRC’s $2.5 million CREATT Centre for asthma research (2020). In 2021, her work on non-pharmacological treatments for interstitial lung diseases won the SPP Robalo Cordeiro Award. Her latest project focuses on minimizing corticosteroid use in asthma. 🫁💡🌿

Research Focus

Assoc. Prof. Dr. Anne Vertigan’s research primarily focuses on respiratory diseases, particularly chronic cough, breathlessness, and asthma. She investigates the psychophysiological correlates of breathlessness and the impact of exposure to environmental factors like wildfire smoke. Dr. Vertigan also explores respiratory issues related to vocal cord dysfunction and laryngeal hypersensitivity. She is involved in studies aimed at improving diagnostic and therapeutic approaches for conditions such as chronic cough in children and adults. Her work aims to enhance understanding and management of airway conditions in clinical settings. 🌬️🫁👩‍⚕️🔬🌱

Publication top Notes

Abnormal breathing pattern features in chronic refractory cough

Understanding Breathlessness Burden and Psychophysiological Correlates in Asthma

Respiratory Diseases Associated With Wildfire Exposure in Outdoor Workers

Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner’s commentary on Fujiki et al.

Living With Asthma and Vocal Cord Dysfunction/Inducible Laryngeal Obstruction: “I Just Can’t Get Air In”

Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia